Triple

T22863027
Position Surface form Disambiguated ID Type / Status
Subject LOXO-305 E566975 entity
Predicate hasTarget P14889 FINISHED
Object Bruton’s tyrosine kinase NE NERFINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Bruton’s tyrosine kinase | Statement: [LOXO-305, hasTarget, Bruton’s tyrosine kinase]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Bruton’s tyrosine kinase
Context triple: [LOXO-305, hasTarget, Bruton’s tyrosine kinase]
  • A. Bruton tyrosine kinase
    Bruton tyrosine kinase is a key signaling enzyme in B cells that plays a crucial role in their development and function and is a major therapeutic target in certain blood cancers and autoimmune diseases.
  • B. Janus kinase 1
    Janus kinase 1 is a tyrosine kinase enzyme involved in cytokine receptor signaling and immune regulation, making it an important therapeutic target in inflammatory and autoimmune diseases.
  • C. BTK
    BTK is the ICAO airline designator assigned to Batik Air, an Indonesian full-service carrier.
  • D. BTK chosen
    BTK (Bruton’s tyrosine kinase) is a key signaling enzyme in B cells and a major therapeutic target in certain blood cancers and autoimmune diseases.
  • E. CD22
    CD22 is a B-cell–specific surface glycoprotein that functions as an inhibitory co-receptor modulating B cell receptor signaling and immune responses.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e24589083081908d5694c4fdc80086 completed April 17, 2026, 2:36 p.m.
NER Named-entity recognition batch_69f17efdc3b08190be03d856aa86b277 completed April 29, 2026, 3:46 a.m.
Created at: April 17, 2026, 3:38 p.m.